Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-19-018433
Filing Date
2019-04-05
Accepted
2019-04-05 16:33:03
Documents
5
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tv518151_s8.htm S-8 72163
2 EXHIBIT 5.1 tv518151_ex5-1.htm EX-5.1 15330
3 EXHIBIT 23.1 tv518151_ex23-1.htm EX-23.1 2825
4 GRAPHIC image_001.jpg GRAPHIC 6386
5 GRAPHIC image_002.jpg GRAPHIC 1660
  Complete submission text file 0001144204-19-018433.txt   102999
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230741 | Film No.: 19735509
SIC: 2834 Pharmaceutical Preparations